June 6, 2007
Symonds sachs AstraZeneca
By Cory Hopkins
Jon Symonds, CFO for pharmaceutical giant AstraZeneca PLC, will leave the company at the end of July to join investment management firm Goldman Sachs as a managing director.
AstraZeneca has 900 employees at its Westborough facility. Its U.S. corporate headquarters are located in Wilmington, Del.
Symonds joined the company in 1997, when it was known simply as Zeneca. He was instrumental in the negotiations with Swedish pharmaceutical company Astra that led to the merger of the two companies in 1998, the company said.
"I have the utmost respect for Jon's personal and professional capabilities," said Louis Schweitzer, chairman of AstraZeneca. "I regret Jon's decision to leave AstraZeneca, however, the move to Goldman Sachs represents an exciting career challenge for him and I wish him every success with it."
AstraZeneca has 900 employees at its Westborough facility. Its U.S. corporate headquarters are located in Wilmington, Del.
Symonds joined the company in 1997, when it was known simply as Zeneca. He was instrumental in the negotiations with Swedish pharmaceutical company Astra that led to the merger of the two companies in 1998, the company said.
"I have the utmost respect for Jon's personal and professional capabilities," said Louis Schweitzer, chairman of AstraZeneca. "I regret Jon's decision to leave AstraZeneca, however, the move to Goldman Sachs represents an exciting career challenge for him and I wish him every success with it."
WBJ Web Partners
Most Recent
Most Recent
0 Comments